| Tumor stage |
ALNM |
1997 |
p |
1997 |
| |
|
50-59 y |
|
60-69 y |
| Stage Ia-b |
0 |
29 |
n.s. |
23 |
| ≤10 mm |
|
24% |
|
26% |
| Stage Ic |
0 |
54 |
n.s. |
38 |
| 10–20 mm |
|
45% |
|
43% |
| Stage IIA |
1–3 |
26 |
n.s. |
15 |
| 10–20 mm |
|
21% |
|
17% |
| Stage IIB |
>3 |
8 |
n.s. |
9 |
| 20–50 mm |
|
7% |
|
9% |
| Stage III |
<9 |
4 |
n.s. |
5 |
| >50 mm |
|
3% |
|
4% |
| Σ |
|
121 |
|
89 |
ALNM, axillary lymph node metastasis |
